Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$372,397
-$124,703 QoQ
Shares Held
15,465
-12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,957
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ironwood Investment Counsel, LLC holds $31,349,950 across 7 Drug Manufacturers - General names. PFE ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,795 | $16,202,016 | |
| 2 | AMGN |
Amgen Inc
|
20,809 | $7,535,355 | |
| 3 | LLY |
ELI LILLY & Co
|
3,573 | $4,285,563 | |
| 4 | ABBV |
AbbVie Inc.
|
9,119 | $2,294,705 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,171 | $400,624 | |
| 6 | PFE |
Pfizer Inc
This page
|
15,465 | $372,397 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,500 | $259,290 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $372,397 | 15,465 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $497,100 | 17,703 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $415,680 | 16,694 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $429,338 | 16,850 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $400,856 | 16,537 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $432,705 | 17,076 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $432,624 | 16,307 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $580,449 | 20,057 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $669,617 | 23,932 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $630,674 | 22,727 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $912,930 | 31,710 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,347,995 | 40,639 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,420,469 | 38,726 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,762,641 | 43,202 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,277,464 | 44,447 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,203,972 | 50,365 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,275,564 | 62,475 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,350,088 | 64,711 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,564,895 | 128,110 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $5,464,076 | 127,042 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $4,829,367 | 123,324 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,382,888 | 120,974 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $5,308,554 | 144,215 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,824,467 | 131,457 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,152,381 | 126,984 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,743,541 | 114,692 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||